Clear Labels Act

The Clear Labels Act is proposed legislation intended to increase transparency in the pharmaceutical industry. It would require prescription drug labels to clearly identify the location where the medication was manufactured. This initiative addresses concerns about the often-opaque generic drug industry, where manufacturers routinely conceal drugmaking locations. The Act is newsworthy now due to its recent introduction by Senators and renewed focus on pharmaceutical supply chain transparency. A Senate Special Committee on Aging hearing last week criticized manufacturers' lack of transparency, adding momentum to the bill's passage. The Act's relevance lies in its potential to empower consumers with more information about their medications and to hold manufacturers accountable for quality control and safety standards in their production facilities. The Act is a result of yearslong campaign to bring more transparency to the generic drug industry.